1Research Service, VA Hospital, Hines, IL 60141.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Approximately 19-26% of chronic lymphocytic leukemia (CLL) patients have intractable disease resistant to chemotherapy. This intractable CLL is a proliferative disease, unlike the accumulative, responsive form.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: